Treatment of Strokes

Treatment and treatment of stroke "Time is brain" is a repetitive slogan to tackle treatment and management of stroke (Saver, 2006). Timely and appropriate medical treatment during the first few hours of a stroke is important for patient survival and outcome. Recent changes in acute stroke treatment guidelines published by the American Heart Association (AHA) and the American Stroke Association (ASA) have improved the opportunity for patients to receive treatment. Stroke treatment currently complies with myocardial infarction treatment model.

In addition to "neurotrophic" treatment in the rehabilitation of stroke, method. Bone marrow stromal cells (BMSC) have been shown to treat stroke by regulating neurogenesis, angiogenesis, oligodendrocyte production, axonal germination and synaptic development. It has been observed that the major mechanism by which exogenous BMSCs are transplanted is that BMSC can secrete BDNF, NGF, VEGF and hepatocyte growth factor (HGF). In addition, a subpopulation of MSCs has been shown to promote neuronal survival and neurogenesis. It was noticed that NPC proliferation in SVZ and SGZ was enhanced after transplantation of BMSC in experimental ischemic stroke and NPC migration to the affected area was confirmed. BMSCs can also differentiate into endothelial cells in the ischemic brain and stimulate these cells to express VEGF and Ang1.

Remote telepresence medical diagnostic and therapeutic market is particularly important for the treatment of stroke. If symptoms are treated within 4 hours after the onset of symptoms, damage to the stroke will be alleviated. Global Telemedicine Partnership aims to integrate diagnostic tools into remote stroke solutions. A stroke occurs when a blood vessel in the brain ruptures or is occluded by a thrombus. There are two types of stroke: hemorrhagic and ischemic. Ischemic stroke occurs as a result of occlusion of blood vessels supplying blood to the brain, accounting for 87% of all stroke cases. Haemorrhagic stroke occurs when weak blood vessels rupture and splash blood on brain tissue. There are 800,000 people in the United States, and 15 million people worldwide suffer a stroke every year.

Market share of telepresence robots, success of analysis by key participants, challenges and strategies 2016-2022

The number of treatments available when someone stroke is very limited. In the case of a stroke caused by a thrombus, the two main treatments are surgical procedures to remove drugs and thrombi, called thrombolytics (which destroy thrombus). The medicine used to dissolve the thrombus increases the risk of cerebral hemorrhage and is therefore dangerous to people with hemorrhagic stroke.